{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:40:03Z","timestamp":1785944403923,"version":"3.56.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00586","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T16:48:22Z","timestamp":1558457302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus"],"prefix":"10.3389","volume":"10","author":[{"given":"Wei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengda","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Fu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1668","article-title":"Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance","volume":"338","author":"Adler","year":"2009","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejps.2009.07.001","article-title":"Influence of pellet aggregate populations on the variability of pellet filling into hard shell capsules: a comparison of experiment and computer simulation","volume":"38","author":"Ali","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2337\/diacare.21.1.S32","article-title":"Nutrition recommendations and principles for people with diabetes mellitus","volume":"85","year":"1998","journal-title":"J. Florida Med. Assoc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1021\/jm050261p","article-title":"Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes","volume":"48","author":"Augeri","year":"2005","journal-title":"J. Med. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/dmrr.2514","article-title":"Physical exercise as therapy for type 2 diabetes mellitus","volume":"30","author":"Balducci","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.diabres.2006.08.015","article-title":"Beta-cell preservation with thiazolidinediones","volume":"76","author":"Campbell","year":"2007","journal-title":"Diabetes Res. Clin. Prac."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1016\/j.lfs.2005.04.017","article-title":"Rimonabant: the first therapeutically relevant cannabinoid antagonist","volume":"77","author":"Carai","year":"2005","journal-title":"Life Sciences"},{"key":"B9","unstructured":"Preparation and application of thiophene derivatives CN201310220390.9\n            Chen WanshengX. F.\n            WuZ.\n            LiC.\n            HanJ.\n            LiangF.\n          2013"},{"key":"B10","unstructured":"Preparation and application of methylnaphtho[1,2-b]furanamides and their salts CN201410596877.1\n            Chen YeW. Y.\n            LiW.\n            ChenY.\n            ZhangL.\n            RenC.\n            YinL.\n          2014"},{"key":"B11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/jdi.12254","article-title":"Epidemic trend of diabetes in China: for the Xiaoren Pan Distinguished Research Award in AASD","volume":"5","author":"Chen","year":"2014","journal-title":"J. Diabetes Investig."},{"key":"B12","unstructured":"Preparation and application of spiro-ganoderma lucidum and its pharmaceutical composition CN201410085456.2\n            Cheng YongxianW. X.\n            PingF.\n            QingLv.\n          2014"},{"key":"B13","unstructured":"Preparation and application of erythritol lactones and their pharmaceutical compositions CN201410085255.2\n            Cheng YongxianY. Y.\n            XinlongW.\n            LinhongZ.\n            JinhuaM.\n            PingF.\n          2014"},{"key":"B14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2337\/dc08-1984","article-title":"The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone","volume":"32","author":"Defronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.micpath.2015.12.005","article-title":"Current recommendations on managing tuberculosis patients with diabetes & its epidemiology","volume":"92","author":"Deng","year":"2016","journal-title":"Microbial Pathogenesis"},{"key":"B17","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s40265-015-0473-z","article-title":"Saxagliptin: a review in type 2 diabetes","volume":"75","author":"Dhillon","year":"2015","journal-title":"Drugs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJM199209033271007","article-title":"Carbohydrate metabolism in non-insulin-dependent diabetes mellitus","volume":"327","author":"Dinneen","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1210\/en.2007-0968","article-title":"Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose","volume":"149","author":"Dov","year":"2008","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell. Metab."},{"key":"B21","article-title":"The PPAR[Gamma] Agonist Rosiglitazone (RSG) Decreases Net Loss of Pancreatic [Beta]-Cell Mass in Zucker Diabetic Fatty Rats","author":"Finegood","year":"1999","journal-title":"Diabetes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/sj.ijo.0801627","article-title":"The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity","volume":"25","author":"Flint","year":"2001","journal-title":"Int. J. Obesity"},{"key":"B23","unstructured":"Preparation and method of traditional Chinese medicine for treating diabetes CN98100516.0\n            GangW.\n          1998"},{"key":"B24","unstructured":"Preparation of glimepiride aqueous solution delivery system CN200810119045.5\n            Gao YongliangT. J.\n            LiuJ.\n            WangJ.\n            LiJ.\n          2008"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(03)72785-2","article-title":"Reducing insulin resistance with metformin: the evidence today","volume":"29","author":"Giannarelli","year":"2003","journal-title":"Diabetes Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12325-014-0101-4","article-title":"Pathophysiological and pharmacological rationale for the use of exenatide once weekly in patients with type 2 diabetes","volume":"31","author":"Grossman","year":"2014","journal-title":"Adv. therapy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2337\/diab.41.12.1575","article-title":"The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents","volume":"41","author":"Gulli","year":"1992","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/1753-0407.12440","article-title":"Secular trends in the prevalence of type 2 diabetes in adults in China from 1995 to 2014: a meta-analysis","volume":"9","author":"Han","year":"2017","journal-title":"J. Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2337\/dc05-1801","article-title":"Measurement of the High\u2013Molecular Weight Form of Adiponectin in Plasma Is Useful for the Prediction of Insulin Resistance and Metabolic Syndrome","volume":"29","author":"Hara","year":"2006","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2337\/db09-1414","article-title":"The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action","volume":"59","author":"Hare","year":"2010","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/00002018-200022040-00004","article-title":"Comparative Tolerability of Sulphonylureas in Diabetes Mellitus","volume":"22","author":"Harrower","year":"2000","journal-title":"Drug Safety"},{"key":"B32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000201231","article-title":"Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients","volume":"56","author":"Herrmann","year":"1995","journal-title":"Digestion"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1210\/jc.2009-0550","article-title":"Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone","volume":"94","author":"Hollander","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00545.2003","article-title":"Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans","volume":"287","author":"Holst","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.2337\/dc11-s227","article-title":"Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes","volume":"34","author":"Holst","year":"2011","journal-title":"Diabetes Care"},{"key":"B36","unstructured":"Preparation and application of thiazolidinedione derivative CN201210202455.2\n            Hu XiangnanX. X.\n            LiuZ.\n            FengY.\n            ChenY.\n            MingY.\n            TaoZ.\n          2012"},{"key":"B37","unstructured":"Preparation of low molecular fucoidan sulfate and its application to diabetic nephropathy CN201410029573.7\n            Ji AiguoS. S.\n            LiangH.\n            WangX.\n          2014"},{"key":"B38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/978-3-7091-9334-1_64","article-title":"Free fatty acid liberation and cellular swelling during cerebral ischemia: the role of excitatory amino acids","volume":"60","author":"Katayama","year":"1994","journal-title":"Acta. Neurochir. Suppl."},{"key":"B39","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2337\/diab.38.7.902","article-title":"Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide","volume":"38","author":"Komatsu","year":"1989","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1210\/rp.56.1.265","article-title":"Insulin resistance and its treatment by thiazolidinediones","volume":"56","author":"Lebovitz","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1464-5491.2005.01605.x","article-title":"\u03b2-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes","volume":"22","author":"Leiter","year":"2005","journal-title":"Diabetic Med. J. Br. Diabetic Assoc."},{"key":"B42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.accreview.2005.06.021","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"14","author":"Van Gaal","year":"2005","journal-title":"ACC Curr. J. Rev."},{"key":"B43","unstructured":"Preparation and application of saponin A CN201210564022.1\n            Li JiaG. Y.\n            ZhouZ.\n            LiuH.\n            GaoL.\n          2012"},{"key":"B44","unstructured":"Preparation and application of polynuclear compounds synthesized from berberine and magnolol CN201410015130.2\n            Li WeiminY. X.\n            RongX.\n            ZhouD.\n          2014"},{"key":"B45","first-page":"340","article-title":"Prevention of type 2 diabetes in the population with impaired glucose tolerance by metformin and diet fibre","volume":"10","author":"Li","year":"2002","journal-title":"Chin. J. Diabetes"},{"key":"B46","unstructured":"Preparation and application of long-acting enterosteroid polypeptide analogues for the treatment of type 2 diabetes CN201410243272.4\n            Li YingG. J.\n            YuanY.\n          2014"},{"key":"B47","unstructured":"Preparation and application of two terphenyldioxazine derivatives CN201410056590.X\n            Liu HongweiM. K.\n            HanJ.\n            BaoL.\n          2014"},{"key":"B48","unstructured":"Preparation and application of a xanthohumol for preparing medicine or health care product for inhibiting \u03b1-glucosidase activity CN201410004543.0\n            Liu MingM. J.\n            GeL.\n          2014"},{"key":"B49","unstructured":"Traditional Chinese medicine for treating diabetes CN200910117610.9\n            Liu XinZ. Z.\n            ZhaoK.\n          2009"},{"key":"B50","unstructured":"Application of mangiferin derivatives in the preparation of drugs for diabetes and its complications CN201410474355.4\n            Liu YidanS. Z.\n            XujuanY.\n            LimingS.\n            PingW.\n            XiaoyingL.\n            ZhangJ.\n          2014"},{"key":"B51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-alpha in mice","volume":"54","author":"Maida","year":"2011","journal-title":"Diabetologia"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0149-2918(00)83060-X","article-title":"Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review","volume":"22","author":"Malinowski","year":"2000","journal-title":"Clin. Ther."},{"key":"B53","unstructured":"Method for extracting \u03b1-tocopherol in the genus Pteridium CN201410608322.4\n            Mao ShuichunL. J.\n            GuoY.\n            LiuD.\n          2014"},{"key":"B54","unstructured":"Preparation and application of steroidal ketone ketone CN201410335098.6\n            Mao ShuichunL. J.\n            GuoY.\n            LiuD.\n            YangP.\n          2014"},{"key":"B55","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/0140-6736(92)92814-V","article-title":"Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study","volume":"340","author":"Martin","year":"1992","journal-title":"Lancet (London, England)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2174\/1389450117666151209122702","article-title":"GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges","volume":"17","author":"Mohammad","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01838.x","article-title":"Mortality in people with type 2 diabetes in the UK","volume":"23","author":"Mulnier","year":"2006","journal-title":"Diabetic Med. J. Br. Diabetic Assoc."},{"key":"B59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainres.2011.11.012","article-title":"Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system","volume":"1432","author":"Nakamoto","year":"2011","journal-title":"Brain Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1021\/ml1000855","article-title":"Discovery of TAK-875: a potent, selective, and orally bioavailable GPR40 Agonist","volume":"1","author":"Negoro","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"B61","first-page":"214","article-title":"Future detection and monitoring of diabetes may entail analysis of both beta-cell function and volume: how markers of beta-cell loss may assist","volume-title":"J. Transl. Med.","author":"Neutzsky-Wulff","year":"2012"},{"key":"B62","unstructured":"Preparation method of diaphorin vanadium complex with hypoglycemic activity CN201510018112.4\n            Ning GuilinD. L.\n            YeJ.\n            GongW.\n            LinY.\n            NaD.\n          2015"},{"key":"B63","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3109\/00365529609009147","article-title":"Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day","volume":"31","author":"Orskov","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707529","article-title":"GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity","volume":"153","author":"Overton","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1185\/03007990903350011","article-title":"Efficacy and safety of pioglitazone\/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM","volume":"25","author":"Perez","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"B66","doi-asserted-by":"crossref","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"B67","doi-asserted-by":"crossref","DOI":"10.1007\/PL00002947","article-title":"Increasing incidence of childhood-onset type 1 diabetes in 3 Baltic countries and Finland","volume":"44","author":"Podar","year":"2001","journal-title":"Diabetologia"},{"key":"B68","first-page":"57","volume":"138","author":"Raheli\u0107","year":"2016","journal-title":"Lijec Vjesn"},{"key":"B69","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"New Engl. J. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1463-1326.2007.00755.x","article-title":"The effect of thiazolidinediones on adiponectin serum level: a meta-analysis","volume":"10","author":"Riera-Guardia","year":"2008","journal-title":"Diabetes Obesity Metab."},{"key":"B71","unstructured":"Preparation and application of an isobenzofuranone compound CN201310692094.9\n            She ZhigangL. Y.\n            MaL.\n            LiH.\n            XiaG.\n            LuY.\n          2013"},{"key":"B72","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/pgmj.2008.067918","article-title":"Recent advances in the management of type 2 diabetes mellitus: a review","volume":"84","author":"Srinivasan","year":"2008","journal-title":"Postgraduate Med. J."},{"key":"B73","unstructured":"Preparation of a new 23,29-norsole oleic acid compound and the application for preparing glycosidase inhibitor drugs CN201310737166.7\n            Tan JianwenW. J.\n            XuQ.\n            ZhouZ.\n            RenH.\n          2013"},{"key":"B74","unstructured":"Preparation of a new 23-lower oleic acid compound and its role in glycosidase inhibitor drugs CN201310737187.9\n            Tan JianwenW. J.\n            ZhouZ.\n            RenH.\n            XuQ.\n          2013"},{"key":"B75","unstructured":"Preparation for one traditional Chinese medicine CN201510188449.X\n            Tan XiaozhongS. Y.\n            QuQ.\n            WangL.\n            FuS.\n            LiZ.\n            ZhangS.\n          2015"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00326.2004","article-title":"Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP","volume":"290","author":"Theodorakis","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"C558","DOI":"10.1152\/ajpcell.00148.2015","article-title":"Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus","volume":"310","author":"Urbano","year":"2016","journal-title":"Ajp Cell Physiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2147\/VHRM.S3119","article-title":"Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes","volume":"4","author":"van de Laar","year":"2008","journal-title":"Vascular Health Risk Manage"},{"key":"B79","unstructured":"Application of valerian pentacyclic triterpenoid saponin for preparing hypoglycemic drugs CN201310627408.7\n            Wang XueyongZ. B.\n          2013"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012633","article-title":"Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: a system review and meta-analysis","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"key":"B81","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00125-013-3129-0","article-title":"Laparoscopic adjustable gastric banding and progression from impaired fasting glucose to diabetes","volume":"57","author":"Wentworth","year":"2014","journal-title":"Diabetologia"},{"key":"B82","unstructured":"Preparation and application of lupin-type triterpenoids and their pharmaceutical compositions CN201410177372.1\n            Xu GangS. X.\n            MaJ.\n            TanJ.\n          2014"},{"key":"B83","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.bbadis.2016.09.019","article-title":"Metformin, beyond an insulin sensitizer, targeting heart and pancreatic \u03b2 cells","volume":"1863","author":"Yang","year":"2017","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"B84","unstructured":"Application of scrotonin and its homologues in the preparation of drugs for treating diabetic complications CN201410005910.9\n            Yu ChangxiL. M.\n            LingQ.\n            XuY.\n            HuangH.\n            YangJ.\n            SuY.\n          2014"},{"key":"B85","unstructured":"Method for preparing a GPR40 agonist pharmaceutical composition CN201711429787.3\n            Zhang DaimeiD. H.\n            TingtingZ.\n          2017"},{"key":"B86","unstructured":"Method for preparing a polymer as DPP-4 inhibitor CN201210418156.2\n            Zhang XiaoqingS. Z.\n            BaoJ.\n            JiangY.\n          2012"},{"key":"B87","unstructured":"Preparation and application of novel urea-substituted biphenyl compounds and their derivatives CN201410429055.4\n            Zhang YingjunY. X.\n            WangX.\n            MaF.\n            WuS.\n            ZhengC.\n            XuJ.\n          2014"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1002\/chin.200552163","article-title":"Diprolyl Nitriles as Potent Dipeptidyl Peptidase IV Inhibitors","volume":"36","author":"Zhao","year":"2005","journal-title":"Cheminform"},{"key":"B89","unstructured":"New application of golden gray chlorophyll-like compounds CN201410112149.9\n            Zheng ZhihuiL. X.\n            XuY.\n            ZhengH.\n            KeA.\n            RenX.\n            LiY.\n          2014"},{"key":"B90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nature reviews. Endocrinology"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00586\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T11:30:16Z","timestamp":1559561416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00586\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":90,"alternative-id":["10.3389\/fphar.2019.00586"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00586","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"article-number":"586"}}